White Blood Cell Count and the Risk of Coronary Heart Disease and All-Cause Mortality in Elderly Men

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 4, 1996, Pages 499-503

  Weijenberg, M P ^a   Feskens, E J M ^a   Kromhout, D ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Coronary heart disease; Elderly; Follow up; Mortality; White blood cell count

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BODY MASS; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CORONARY DISEASE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LEUKOCYTE COUNT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MORTALITY; NETHERLANDS; RISK FACTORS; SMOKING;

EID: 0029919298     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.4.499     Document Type: Article

References (27)

1. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation. 1991;83:836-844.
2. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med. 1974;290:1275-1278.
3. Zalokar JB, Richard JL, Claude JR. Leukocyte count, smoking and myocardial infarction. N Engl J Med. 1981;304:465-468.
4. Olivares R, Ducimetière P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol. 1993;137:49-53.
5. Kannel WB, Anderson K, Wilson PWF. White blood cell count and cardiovascular disease: insights from the Framingham Study. JAMA. 1992;267:1253-1256.
6. Phillips AN, Neaton JD, Cook DG, Grimm RH, Shaper AG. Leukocyte count and risk of major coronary heart disease events. Am J Epidemiol. 1992;136:59-70.
7. Gillum RF, Ingram DD, Makuc DM. White blood cell count, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J. 1993;125:855-863.
8. Grimm RH, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA. 1985;254:1932-1937.
9. Ensrud K, Grimm RH. The white blood cell count and risk for coronary heart disease. Am Heart J. 1992;124:207-213.
10. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic diseases. JAMA. 1987;257:2318-2324.
11. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women: review of an NHLBI workshop. Ann Epidemiol. 1992;2:161-176.
12. Bulpitt CJ, Fletcher AE. Prognostic significance of blood pressure in the very old: implications for the treatment decision. Drugs Aging. 1994;5:184-191.
13. Kaplan GA, Haan MN, Cohen RD. Risk factors and the study of prevention in the elderly: methodological issues. In: Wallace RB, Woolson RF, eds. The Epidemiologic Study of the Elderly. New York, NY: Oxford University Press; 1992:20-36.
14. Barth JD, Arntzenius AC. Progression and regression of atherosclerosis, what roles for LDL-cholesterol and HDL-cholesterol: a perspective. Eur Heart J. 1991;12:952-957.
15. Fuster V, Lewis A. Conner Memorial Lecture: mechanisms leading to myocardial infarction-insights from studies of vascular biology. Circulation. 1994;90:2126-2146.
16. Keys A, Aravanis C, Blackburn HW, van Buchem FSP, Buzina R, Djordjevid BS, Dontas AS, Fidanza F, Karvonen MJ, Kimura N, Lekos D, Monti M, Puddu V, Taylor HL. Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand. 1967;460(suppl):1-392.
17. Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW. Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem. 1981;19:838-839.
18. Stähler F, Gruber W, Stinshoff K, Röschlau P. Eine praxisgerechte enzymatische cholesterin-bestimmung. Med Lab. 1977;30:29-37.
19. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
20. Rose GA, Blackburn H. Cardiovascular Survey Methods. Geneva, Switzerland: World Health Organization; 1968.
21. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, 1975 (Ninth) Revision. Geneva, Switzerland: World Health Organization; 1977.
22. SAS Technical Report P-217, SAS/STAT® Software: The PHREG Procedure, version 6. Cary, NC: SAS Institute Inc; 1991.
23. Weijenberg MP, Feskens EJM, Kromhout D. Total and high density lipoprotein cholesterol as risk factors for coronary heart disease in elderly men during five years of follow-up: the Zutphen Elderly Study. Am J Epidenuol. 1996;143:151-158.
24. Alexander RW. Inflammation and coronary artery disease. N Engl J Med. 1994;331:468-469.
25. Änggård E. Nitric oxide: mediator, murderer, and medicine. Lancet. 1994;343:1199-1206.
26. De Labry LO, Campion EW, Glynn RJ, Vokonas PS. White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. J Clin Epidemiol. 1990;43:153-157.
27. LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb D, Evans D, Hennekens CH. Smoking and mortality among older men and women in three communities. N Engl J Med. 1991;324:1619-1625.